EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anticancer Activity of Miswak Root Extract in Breast Cancer Cell Line: HRLC-MS/MS Profiling, In Vitro Evaluation, and In Silico Analysis

Abrar Turki iD, Md Abul Barkat iD, Yasmin Basheer Ahmed iD, Harshita Barkat, Raghad Rashed Alotaibi, Khursheed Ahmad, Rumana Ahmad, Sahabjada Siddiqui iD

International Journal of Molecular Sciences · 25.06.2026 · 27 (13) · 5751

DOI: 10.3390/ijms27135751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.06.2026. Verfasst von Abrar Turki und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Nutrition Department, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia. Hauptthemen laut MEDLINE: Plant Extracts, Plant Roots, Breast Neoplasms, Antineoplastic Agents, Phytogenic. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is among the most commonly diagnosed malignancies in women and remains difficult to treat due to therapy resistance and the adverse effects associated with conventional chemotherapeutic regimens. In this study, the anticancer activity of the ethanolic root extract of Salvadora persica (S. persica), commonly known as Miswak, was evaluated in human breast cancer cells using a combination of in vitro assays, phytochemical profiling, and computational analyses. HRLC-MS/MS characterization revealed a wide range of bioactive constituents, including alkaloids, flavonoid derivatives, glucosinolates, and fatty acid–based molecules detected under both ionization modes. The extract exhibited a concentration-dependent cytotoxic effect on breast cancer MCF-7 and MDA-MB-231 cells, with IC50 values of 144.1 and 176.3 µg/mL, respectively, as determined by the MTT assay, while exerting negligible toxicity toward normal Vero cells. Miswak extract enhanced intracellular ROS production, disruption of MMP, nuclear condensation, and increased apoptotic cell populations, along with S-phase cell cycle arrest, pointing toward activation of mitochondrial-mediated apoptosis. In silico docking results indicated that key phytoconstituents exhibit strong binding interactions with multiple breast cancer–relevant targets such as ERα, PR, EGFR, HER3, IGF-1R, and GPER. Additionally, pharmacokinetic and toxicity predictions suggested favorable drug-like properties with minimal safety concerns. Thus, these findings support its potential as a promising plant-derived therapeutic candidate for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsPlant RootsBreast NeoplasmsAntineoplastic Agents, PhytogenicHumansFemaleTandem Mass SpectrometryMCF-7 CellsApoptosisAnimalsMDA-MB-231 CellsMolecular Docking SimulationVero CellsReactive Oxygen SpeciesChlorocebus aethiopsCell Line, TumorCell ProliferationComputer Simulation

Stichwörter der Autor:innen

HRLC-MS/MS characterizationMCF-7 breast cancer cell lineMiswak rootanti-cancer potentialcomputational analysis

Substanzen

Plant ExtractsAntineoplastic Agents, PhytogenicReactive Oxygen Species

Autor:innen und Institutionen

  • Clinical Nutrition Department, College of Applied Medical Sciences, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, University of Hafr Al Batin, Hafr Al Batin 39524, Saudi Arabia.
  • Department of Biotechnology, Era's Lucknow Medical College and Hospital, Era University, Lucknow 226003, India.
  • Department of Biochemistry, Era's Lucknow Medical College and Hospital, Era University, Lucknow 226003, India.

ORCID-Profile: Abrar Turki, Md Abul Barkat, Yasmin Basheer Ahmed, Sahabjada Siddiqui

Förderung

  • Ministry of Education

Zitieren

APA

Turki, A., Barkat, M. A., Ahmed, Y. B., Barkat, H., Alotaibi, R. R., Ahmad, K., Ahmad, R., & Siddiqui, S. (2026). Anticancer Activity of Miswak Root Extract in Breast Cancer Cell Line: HRLC-MS/MS Profiling, In Vitro Evaluation, and In Silico Analysis. International Journal of Molecular Sciences, 27(13), 5751. https://doi.org/10.3390/ijms27135751

Vancouver

Turki A, Barkat MA, Ahmed YB, Barkat H, Alotaibi RR, Ahmad K, et al. Anticancer Activity of Miswak Root Extract in Breast Cancer Cell Line: HRLC-MS/MS Profiling, In Vitro Evaluation, and In Silico Analysis. International Journal of Molecular Sciences. 2026;27(13):5751. doi:10.3390/ijms27135751

BibTeX
@article{Turki2026,
  author = {Turki, Abrar and Barkat, Md Abul and Ahmed, Yasmin Basheer and Barkat, Harshita and Alotaibi, Raghad Rashed and Ahmad, Khursheed and Ahmad, Rumana and Siddiqui, Sahabjada},
  title = {Anticancer Activity of Miswak Root Extract in Breast Cancer Cell Line: HRLC-MS/MS Profiling, In Vitro Evaluation, and In Silico Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {5751},
  doi = {10.3390/ijms27135751}
}
Kostenlos starten →